WednesdayFeb 14, 2024 2:54 pm

CBDNewsBreaks – Software Effective Solutions Corp. (d/b/a MedCana) (SFWJ), Subsidiary Ink Multiyear Deal with Danziger Colombia

Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) and its majority-controlled subsidiary, Eko2o Environmental Solutions S.A.S., have signed a multiyear contract with Danziger Colombia. According to the announcement, the agreement outlines plans for Colombia-based Eko2o, a leading provider of greenhouse infrastructure and agricultural technology, to provide greenhouse infrastructure services, irrigation products and technology to Danziger’s flower operations in Colombia. The company anticipates the agreement, which marks a pivotal moment for both organizations in their commitment to innovative agricultural practices, will result in between $2.5 million and $3 million in revenue over the next three years. Eko2o specializes in providing state-of-the-art…

Continue Reading

FridayDec 08, 2023 10:55 am

CBDNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Update on FDA Application for Investigational Drug

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is planning to submit an Investigational New Drug (“IND”) application with the U.S. Food and Drug Administration (“FDA”) in the next 45 days. The application is for the company’s planned U.S. phase 1b Hypertension Clinical Trial. The filing had been delayed for necessary documentation from a raw material supplier, which is now being provided, enabling Lexaria to finalize the IND application. According to the announcement, the supplier anticipates providing the final two pieces of outstanding information to the FDA within the next 45 days, after which Lexaria can proceed…

Continue Reading

MondayAug 15, 2022 11:55 am

CBDNewsBreaks – LFTD Partners Inc. (LIFD) Releases Q2 2022 Financial Report

LFTD Partners (OTCQB: LIFD), the corporate parent of leading cannabis and psychedelics manufacturer Lifted Made, is reporting on its second quarter 2022, which is the period ended June 30, 2022. Highlights of the report include revenue for the quarter totaling $16,776,502, a 151% increase from the $6,695,144 reported in Q2 2021, and an increase in operating margin of 3.14%, with Q2 2022 coming in at 26.40%. GAAP net income from the quarter increased — the eighth consecutive quarter of upward movement — totaling $3,219,460 up from $1,596,154 the same period last year. The company reported a 64% increase in basic…

Continue Reading

ThursdayMay 19, 2022 2:38 pm

CBDNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Aims to Deliver Safer Alternative for Nicotine Experience

Lexaria Bioscience Corp. (NASDAQ: LEXX) will soon begin a human clinical study, NIC-H22-1, to compare its DehydraTECH-nicotine pouch performance with that of existing brands such as ON! and Zyn, currently available in the U.S. “Animal testing has already demonstrated that DehydraTECH-nicotine can deliver peak nicotine performance to the bloodstream 10 to 20 times faster than the study’s controls,” a recent article reads. “Lexaria has long held that any form of inhaling chemical substances can be detrimental to health, and its DehydraTECH-nicotine aims to help vapers as well as smokers wean themselves off of those products, giving them relief from cravings…

Continue Reading

TuesdayJan 25, 2022 2:28 pm

CBDNewsBreaks – Vantage Hemp Co. is in the Final Stages of its DMF Submissions

The usage of CBD as an active pharmaceutical ingredient is creating an overwhelming need for CBD manufacturers to identify their processes used in the manufacturing, packaging, and storing of pharmaceutical drug ingredients. On their way to set the industry bar, Colorado-based CBD manufacturer, Vantage Hemp Co., announces the company is in its final stages of its Drug Master File submissions to the US Food & Drug Administration. As one of the first CBD companies to file DMFs for all of its ingredients, Vantage is providing the FDA with confidential and detailed information about the quality and safety of its products. These submissions can…

Continue Reading

MondayDec 06, 2021 1:20 pm

CBDNewsBreaks – Grapefruit USA Inc. (GPFT) Launches World’s Most Effectively Bioavailable CBD Delivery Cream

Grapefruit USA (OTCQB: GPFT), a premiere California-based cannabis and hemp company, today announced the official launch of the world’s first patented time-release, hemp-based CBD topical cream with boosted bioavailability, made possible by its proprietary Hourglass(TM) technology. Hourglass, a unique method for topical delivery of CBD, leverages a proprietary process that involves the grinding of CBD into nano-sized particles, substantially smaller than the width of a human hair, which allows for significantly higher bioavailability and absorption. “Over the last several months, our Hourglass product team has received extremely positive product feedback and internal reviews from our product testers and retail customers…

Continue Reading

MondayNov 29, 2021 12:33 pm

CBDNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Inks Agreements with Leading Health and Beauty Company, CBD Beverage Company

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has signed a definitive agreement with Avaria Health & Beauty Corp. Based on the agreement, the two companies will form a joint venture (“JV”), named FloVaria Corp., aimed to facilitate the sale of its award-winning KaLaya brand; sales efforts will be directed in Latin America (“LATAM”). KaLaya has currently sold more than a million units throughout Canada and is carried in major retail locations including Walmart and Loblaws, where the brand has earned the number-two customer loyalty rating in the natural-value, skin-care category. The agreement…

Continue Reading

MondayNov 15, 2021 11:32 am

CBDNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Closes Acquisition of Vessel Brand Inc.

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has completed the acquisition of Vessel Brand Inc., an industry leader in cannabis consumer technology. According to Flora Growth, the acquisition provides the company with an immediate foothold in the North American cannabis market because Vessel brings with it a trailing 12-months revenue of $6.6 million and year-over-year growth of 90%. In addition, the acquisition diversifies Flora’s premium brand portfolio through Vessel’s strong position in the luxury cannabis consumer technology market. According to the announcement, key Vessel team members will join Flora’s executive bench and…

Continue Reading

ThursdayNov 04, 2021 3:37 pm

CBDNewsBreaks – Endexx Corporation’s (EDXC) Popular Blesswell(TM) to Hit Shelves of Major Retail Chain

Endexx (OTC: EDXC), a provider of innovative hemp-derived cannabidiol (“CBD”) wellness and health products, today announced its receipt of a vendor number and cleared compliance with a major well-known drug chain for the placement of its BlessWell(TM) product line. Endexx has already begun the process of preparing products for shipment and placement by year-end into the national chain, and the initial arrangement will target approximately 1,000 stores in North America. The men’s skin care line, Blesswell, launched in May 2021 with famed record producer and music mogul, DJ Khaled. Blesswell has received high praise and mass exposure recently as many…

Continue Reading

MondayNov 01, 2021 1:33 pm

CBDNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Begins R&D Program Comparing DehydraTECH-CBD with Generic CBD, Epidiolex

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has begun a new study, EPIL-A21-1,designed to evaluate whether its DehydraTECH(TM)-CBD (“CBD”) indicates superior ability to reduce seizure activity compared to both generic cannabidiol and Epidiolex. Epidiolex is the only CBD medication approved by the U.S. Food and Drug Administration (“FDA”) for the treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome, two rare and severe forms of pediatric epilepsy. Among those involved in the study are respirology and neurobiology experts. According to the announcement, the team of investigators will carefully analyze how DehydraTECH-CBD compares with Epidiolex in treating seizures.…

Continue Reading

CBDWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722